Exploration of French company loyalty dividends, share registration, and bonus dividends, with a focus on favorite dividend payers like Louis Vuitton and insights into Novo Nordisk's diabetes medication in Europe. The chapter also discusses GLP1's versatility for kidney disease treatment, challenges in health insurance reimbursements, and the potential in the healthcare sector.
Welcome to the 200th episode of Dividend Talk! Join us as we celebrate this incredible milestone and reflect on the journey that has brought us here. We owe it all to our loyal listeners. Thank you for your unwavering support!
This episode's main topic is the power of consistent dividend growth investing. From the importance of investing in companies with strong balance sheets to the mantra of sticking to dividends, Derek and eDGI share a wealth of valuable lessons learned over 200 episodes. Discover the key to success: consistency, conviction, and doing.
Tune In and C U on the inside!
----
Become a premium member:
https://www.europeandgi.com/sign-up
Join us on FaceBook:
https://www.facebook.com/groups/dividendtalk